185 related articles for article (PubMed ID: 31913852)
21. In silico rational design of a novel tetra-epitope tetanus vaccine with complete population coverage using developed immunoinformatics and surface epitope mapping approaches.
Bazmara S; Shadmani M; Ghasemnejad A; Aghazadeh H; Pooshang Bagheri K
Med Hypotheses; 2019 Sep; 130():109267. PubMed ID: 31383332
[TBL] [Abstract][Full Text] [Related]
22. Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach.
Adhikari UK; Rahman MM
Infect Genet Evol; 2017 Dec; 56():75-91. PubMed ID: 29107145
[TBL] [Abstract][Full Text] [Related]
23. In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes.
Kobayashi H; Ngato T; Sato K; Aoki N; Kimura S; Tanaka Y; Aizawa H; Tateno M; Celis E
Clin Cancer Res; 2006 Jun; 12(12):3814-22. PubMed ID: 16778109
[TBL] [Abstract][Full Text] [Related]
24. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
Jacobson S; Reuben JS; Streilein RD; Palker TJ
J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
[TBL] [Abstract][Full Text] [Related]
25. In silico T-cell and B-cell Epitope Based Vaccine Design Against Alphavirus Strain of Chikungunya.
Jadoon MH; Rehman Z; Khan A; Rizwan M; Khan S; Mehmood A; Munir A
Infect Disord Drug Targets; 2020; 20(4):523-530. PubMed ID: 31109281
[TBL] [Abstract][Full Text] [Related]
26. Analysis of epitope-based vaccine candidates against the E antigen of the hepatitis B virus based on the B genotype sequence: An in silico and in vitro approach.
Zheng J; Ou Z; Lin X; Wang L; Liu Y; Jin S; Wu J
Cell Immunol; 2018 Jul; 329():56-65. PubMed ID: 29724463
[TBL] [Abstract][Full Text] [Related]
27. Among all human T-cell leukemia virus type 1 proteins, tax, polymerase, and envelope proteins are predicted as preferential targets for the HLA-A2-restricted cytotoxic T-cell response.
Pique C; Connan F; Levilain JP; Choppin J; Dokhélar MC
J Virol; 1996 Aug; 70(8):4919-26. PubMed ID: 8763995
[TBL] [Abstract][Full Text] [Related]
28. A novel multivalent human CTL peptide construct elicits robust cellular immune responses in HLA-A*0201 transgenic mice: implications for HTLV-1 vaccine design.
Sundaram R; Sun Y; Walker CM; Lemonnier FA; Jacobson S; Kaumaya PT
Vaccine; 2003 Jun; 21(21-22):2767-81. PubMed ID: 12798617
[TBL] [Abstract][Full Text] [Related]
29. Human CD4+ T lymphocytes recognize a highly conserved epitope of human T lymphotropic virus type 1 (HTLV-1) env gp21 restricted by HLA DRB1*0101.
Kitze B; Usuku K; Yamano Y; Yashiki S; Nakamura M; Fujiyoshi T; Izumo S; Osame M; Sonoda S
Clin Exp Immunol; 1998 Feb; 111(2):278-85. PubMed ID: 9486393
[TBL] [Abstract][Full Text] [Related]
30. An immunoinformatics and extended molecular dynamics approach for designing a polyvalent vaccine against multiple strains of Human T-lymphotropic virus (HTLV).
Moin AT; Rani NA; Ullah MA; Patil RB; Robin TB; Nawal N; Zubair T; Mahamud SI; Sakib MN; Islam NN; Khaleque MA; Absar N; Shohael AM
PLoS One; 2023; 18(9):e0287416. PubMed ID: 37682972
[TBL] [Abstract][Full Text] [Related]
31. B-cell and T-cell epitope identification with stability analysis of AI-2 import ATP-binding cassette LsrA from S. typhiIn silico approach.
Vijayababu P; Samykannu G; Antonyraj CB; Narayanan S; Basheer Ahamed SI; Perumal P; Piramanayagam S
Microb Pathog; 2018 Oct; 123():487-495. PubMed ID: 30098402
[TBL] [Abstract][Full Text] [Related]
32. The humoral immune response to human T-cell lymphotropic virus type 1 envelope glycoprotein gp46 is directed primarily against conformational epitopes.
Hadlock KG; Rowe J; Foung SK
J Virol; 1999 Feb; 73(2):1205-12. PubMed ID: 9882322
[TBL] [Abstract][Full Text] [Related]
33. An in silico study to unveil potential drugs and vaccine chimera for HBV capsid assembly protein: combined molecular docking and dynamics simulation approach.
Ismail S; Waheed Y; Ahmad S; Ahsan O; Abbasi SW; Sadia K
J Mol Model; 2022 Feb; 28(2):51. PubMed ID: 35112241
[TBL] [Abstract][Full Text] [Related]
34. Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.
Lairmore MD; DiGeorge AM; Conrad SF; Trevino AV; Lal RB; Kaumaya PT
J Virol; 1995 Oct; 69(10):6077-89. PubMed ID: 7545241
[TBL] [Abstract][Full Text] [Related]
35. In silico identification of potential epitopes present in human adenovirus proteins for vaccine design and of putative drugs for treatment against viral infection.
Hossain R; Yasmin T; Hosen MI; Nabi AHMN
J Immunol Methods; 2018 Apr; 455():55-70. PubMed ID: 29371093
[TBL] [Abstract][Full Text] [Related]
36. In Silico Identification of Chikungunya Virus B- and T-Cell Epitopes with High Antigenic Potential for Vaccine Development.
Sánchez-Burgos GG; Montalvo-Marin NM; Díaz-Rosado ER; Pérez-Rueda E
Viruses; 2021 Nov; 13(12):. PubMed ID: 34960629
[TBL] [Abstract][Full Text] [Related]
37. In silico prediction of potential vaccine candidates on capsid protein of human bocavirus 1.
Kalyanaraman N
Mol Immunol; 2018 Jan; 93():193-205. PubMed ID: 29207326
[TBL] [Abstract][Full Text] [Related]
38. An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice.
Bounds CE; Terry FE; Moise L; Hannaman D; Martin WD; De Groot AS; Suschak JJ; Dupuy LC; Schmaljohn CS
Hum Vaccin Immunother; 2017 Dec; 13(12):2824-2836. PubMed ID: 28575582
[TBL] [Abstract][Full Text] [Related]
39. Designing of an epitope-based peptide vaccine against walking pneumonia: an immunoinformatics approach.
Unni PA; Ali AMMT; Rout M; Thabitha A; Vino S; Lulu SS
Mol Biol Rep; 2019 Feb; 46(1):511-527. PubMed ID: 30465133
[TBL] [Abstract][Full Text] [Related]
40. Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.
Shi J; Zhang J; Li S; Sun J; Teng Y; Wu M; Li J; Li Y; Hu N; Wang H; Hu Y
PLoS One; 2015; 10(12):e0144475. PubMed ID: 26641892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
